KaloBios Ties Up Loose Ends For Ch. 11 Plan Confirmation
Bankrupt drug developer KaloBios Pharmaceuticals Inc., formerly helmed by accused fraudster Martin Skhreli, told a Delaware bankruptcy judge Tuesday that it is in the process of resolving issues with clinical trial contracts...To view the full article, register now.
Already a subscriber? Click here to view full article